Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

The Board of Directors of NextCell Pharma AB resolves on a fully guaranteed SEK 25.1 million rights issue

NextCell Pharma AB ("NextCell" or the “Company”) announces that the Board of NextCell Pharma AB has resolved to conduct a fully guaranteed new issue of shares of approximately SEK 25.1 million with preferential rights for the Company's existing shareholders (the "Rights Issue"), subject to approval by an extraordinary general meeting in the Company. The Company’s largest shareholder Diamyd Medical AB and chairman of the Boad of Directors Anders Essen-Möller have undertaken to subscribe for their pro rata share in the Rights Issue. In total, the Rights Issue is covered by subscription

Nokian Tyres is the first tire company to have its ambitious greenhouse gas reduction targets approved

Nokian Tyres plc Company Release May 15, 2020 at 10:00 a.m. Nokian Tyres is the first tire company to have its emissions reduction targets approved by the Science Based Targets initiative (SBTi). The targets covering greenhouse gas (GHG) emissions from Nokian Tyres’ operations (scopes 1 and 2*) are consistent with reductions required to keep climate warming to 1.5°C, what the latest climate science has told us is needed to prevent the most damaging effects of climate change. Nokian Tyres plc commits to reduce GHG emissions by 2030 in the following categories: · scope 1 and 2 GHG

Ahlstrom-Munksjö, Filterpak and K Group to start the production of face masks in Finland

AHLSTROM-MUNKSJÖ OYJ PRESS RELEASE MAY 15, 2020 at 10.00 EEST Ahlstrom-Munksjö, Filterpak and K Group will start in co-operation the production and supply of face masks for civil use in Finland. The first batch of masks will be available at the end of May. In the co-operation, Ahlstrom-Munksjö is responsible for the production of the fiber-based mask materials at its plant in Tampere and Filterpak for the assembly of the masks in Hanko. Finland-based retailer K Group has ordered the masks and will take care of their logistics and supply. The filtration efficiency of the masks is 88%

NoHo Partners begins co-operation negotiations on continuing temporary layoffs due to uncertain market situation

NoHo Partners PlcINSIDE INFORMATION 15 MAY 2020 at 10:00NoHo Partners begins co-operation negotiations on continuing temporary layoffs due to uncertain market situation On 13 March 2020, NoHo Partners announced it would start temporary layoffs, of 90 days at most, in order to minimise the negative financial impact of the coronavirus (COVID-19) on its business. The current temporary layoffs concern nearly all of the Group’s employees, which comprises about 1,300 people. The layoffs are estimated to continue until the end of June 2020.Due to the uncertain market situation NoHo

2020 Bulkers Ltd. (2020) – Time charter agreements for Bulk Sao Paulo and Bulk Santos

Hamilton, Bermuda, May 15, 2020 2020 Bulkers has entered into time charter agreements for Bulk Sao Paulo and Bulk Santos with a 100% owned subsidiary of Glencore. The vessels will commence their respective 35-37 month time charters upon delivery from New Times Shipyard in early June 2020, and will earn an index-linked rate, reflecting a significant premium to the Baltic 5TC index. The time charters also include a profit sharing of any economic benefit derived from operating the vessels scrubbers, as well as certain rights to convert the time charters to fixed rates on the basis of the

BioStock: Immunicum’s immuno-oncology platform shares the spotlight at Cancer Progress conference

The field of immuno-oncology encompasses several strategies to push our own immune system to be more sensitive and reactive to cancer cells and metastases. Swedish biotech Immunicum have developed their own strategy and were asked to present and discuss it on a panel of immuno-oncology experts at the 31st Annual Cancer Progress Conference last week. BioStock caught up with Immunicum’s COO, Sijme Zeilemaker, who represented the company on that panel, to learn more about the discussion and how Immunicum is making a difference in the field.Read the full interview with Sijme Zeilemaker at

Interim Report 1 January to 31 March 2020

Summary of the interim reportFirst Quarter (1 January to 31 March 2020) · Operating revenue KSEK 0 (0) · Income after financial items KSEK -10 183 (-6 757) · Earnings per share -0,21 (-0,18) · Cash and cash equivalents as of 31 March KSEK 51 831 (30 049) · Equity ratio as of 31 March 95,5 (90,3) % Significant events during the first quarter of 2020 · Cyxone announced in January that the company has ordered more Rabeximod substance earlier than planned. As a result, the first patient in the clinical Phase IIb trial is expected to be dosed in the first quarter of 2021.

Aqilion publishes the Annual Report for 2019

Helsingborg, Sweden – May 15, 2020 – AQILION AB announces today that the Annual Report for 2019 is now available in Swedish on the Company’s website. The report summarizes the Company’s business operations, strategy and financial results. The Annual Report for 2019 is available as a PDF version on the Company’s website, under Corporate, link https://www.aqilion.com/en/financial-reports/.  For more information, please contactSarah FredrikssonCEO, AQILION ABCell phone +46 (0)70 261 4575Email sarah.fredriksson@aqilion.com About AQILION ABAqilion is a Swedish life science

Cantargia presents new preclinical data on CAN04 in combination with chemotherapy at the 2020 AACR Annual Meeting

Cantargia AB (“Cantargia”) today announced that new preclinical data supporting the combination of the clinical stage antibody CAN04, with platinum-based chemotherapy will be presented in two poster presentations at the 2020 Annual Meeting of the American Association for Cancer Research (AACR), June 22-24.Cantargia develops antibody-based pharmaceuticals against interleukin-1 receptor accessory protein (IL1RAP). The antibody CAN04 binds IL1RAP with high affinity and functions through both Antibody-Dependent Cellular Cytotoxicity (ADCC) and blockade of interleukin-1 signaling. CAN04 is

RLS GLOBAL AB (publ) INTERIM REPORT, Q1, 2020

JANUARY 1[st] - MARCH 31[st] · Net sales amounted to TSEK 374 (260 TSEK) · The operating loss for the period was MSEK -3.9 (-5.7 MSEK) · Earnings per share after dilution at SEK -0.06 (-0.04) · Cash flow from operating activities amounted to MSEK -4.2 (-5.5 MSEK) · Equity ratio was 92 percent (84 percent)NOTABLE EVENTS DURING THE PERIOD · A success for the clinical trial ChloraSolv01 where we have included all patients · Revisions of Lloyd’s regarding our quality assurance system and of Eurofins, which is our new Notified Body for directives of medical devices. The

GARO acquires EV Charge Partner Sweden AB

On May 15, 2020, GARO AB (publ) signed an agreement to acquire 70 percent of the shares in EV Charge Partner Sweden AB. The company performs service and support as well as commissioning of charging infrastructure for mainly large operators of charging infrastructure and utility companies in Sweden and Poland.The purchase price amounts to MSEK 5.6 for 70 percent of the shares in EV Charge Partner. The shares have been acquired from Davids Elteknik AB and planned date for take over is June 1, 2020. EV Charge Partners' operations are conducted in a facility in Gnosjö, which is leased from

Rejlers invests in energy management consulting

The Swedish energy market is facing major changes. The opportunities and challenges of the future place increasing demands on today's energy companies in terms of their strategic choices and capacity for change. The need for management expertise is increasing, and Rejlers is now expanding its service portfolio to include Management Consulting aimed at the energy industry. The focus is on helping energy companies to make important strategic decisions associated with the conditions of the energy landscape of the future.Thanks to its many years of collaboration with the majority of Swedish

Concentric’s patented dual cone clutch (DCC) selected for use in truck brake air compressors

Concentric AB has been awarded a contract to supply its new Dual Cone Clutch (DCC) to a Tier 1 brake air compressor manufacturer for use in on-highway applications with one of the world’s leading OEM’s of trucks, buses, construction equipment and industrial engines.  Production will start in 2022/23, with total revenues through to the end of 2026 estimated to SEK 60 million. Significant benefits have been identified for long haul truck applications, where the DCC enables the brake air compressor to be switched off for more than 80% of the running time, reducing fuel consumption and more

Asetek Receives Order from Server OEM Partner

Aalborg, Denmark, 15 May 2020 – Asetek today announced receipt of a purchase order from an OEM Partner. The order value is approximately USD 300,000, with delivery expected to be completed in Q3 2020.  About AsetekAsetek, the creator of the all-in-one liquid cooler, is the global leader for liquid cooling solutions for high performance gaming and enthusiast PCs, and environmentally aware data centers. Founded in 2000, Asetek is headquartered in Denmark and has operations in China, Taiwan and the United States. Asetek is listed on the Oslo Stock Exchange (ASETEK.OL).  www.asetek.com

Etrion completes the sale of its last non-core solar asset

May 15, 2020, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), an independent solar power producer, has sold its 70% ownership in PV Salvador, a solar power plant operating in northern Chile, to Innergex Renewable Energy Chile Spa. Marco Antonio Northland, Etrion’s Chief Executive Officer, commented: “I am pleased to complete the sale of our solar park in Chile. This was our last non-core asset outside of Japan which was carried at zero value on our balance sheet after being fully deconsolidated in September 2017. The Salvador sale allows Etrion

Notice of Investor AB’s Annual General Meeting on June 17, 2020

Investor AB (publ) summons to the Annual General Meeting (the “Meeting”) on Wednesday, June 17, 2020. Due to the corona virus, the Meeting will be carried out through advance voting pursuant to temporary legislation. No Meeting with the possibility to attend physically, in person or by proxy, will take place. An interview session with the Chair of the Board Jacob Wallenberg and the President Johan Forssell, where they together discuss Investor's business, challenges and opportunities and answer a number of questions received, will be available on Investor's website, www.investorab.com,

Redeye: I-Tech - Exciting Time Ahead

Redeye regards I-Tech as fairly valued on the back of a Q1-report somewhat weaker than we had expected. Following a strong run in the share, we believe the market has discounted mild Corona Virus effects, now trading above our current fair value. We remain positive to the company's progress, with largely unchanged estimates, implying a strong outlook for sales and earnings in the coming years. Read more and download the research update: https://bit.ly/2zB9hKy Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a

The Nomination Committee’s proposal for election of members of the Board of Directors of Investor AB

The Nomination Committee of Investor AB submits the following proposals for resolution at the Annual General Meeting of shareholders on June 17, 2020, with regard to the number and election of members of the Board of Directors. The Nomination Committee proposes ten members of the Board of Directors and no deputy members of the Board of Directors.  The Nomination Committee proposes the following persons for re-election as members of the Board of Directors: Gunnar Brock, Johan Forssell, Magdalena Gerger, Tom Johnstone, Sara Mazur, Grace Reksten Skaugen, Hans Stråberg, Lena Treschow

Interim financial report Q1 2020

“I’m pleased with a very good first quarter for H+H despite operating in uncertain times”, says CEO Michael T. Andersen. “Market demand was strong throughout the quarter, where only the UK construction market was affected by a governmental lockdown in the last week of March. Our activities in Continental Europe are currently well performing according to original plan. A gradual reopening of construction sites in the UK has been initiated early May, but visibility remains very low”.    Financial highlights for the period 1 January to 31 March 2020 DKK million

Alzinova AB interim report January – March 2020

The Board of Directors and the Chief Executive Officer of Alzinova AB hereby present the interim report for the first quarter 2020.Three months (2020-01-01 – 2020-03-31)  · Net sales amounted to SEK 0 (SEK 0).  · Result after financial items amounted to SEK -1,774,906 (SEK -1,170,594).   · Earnings per share amounted to SEK -0.23 (SEK -0.16).  · Solidity amounted to 91.8% (95.4%). Significant events during the first quarter of 2020 · The Company announced in January that it had ensured a robust and validated process to manufacture API that meets the quality standards

Sale of shares in Boozt AB (publ)

Press release, 15 May 2020 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Verdane Capital VII K/S (“Verdane”) (the “Seller”) has sold 3,092,343 shares in Boozt AB (publ) (“Boozt”) through an accelerated bookbuilding process to Swedish and international institutional investors at a price of SEK 58.50 per share (the “Placing”). Following the Placing, Verdane no longer holds any shares in Boozt. Carnegie and Danske

SinterCast withdraws original dividend proposal

Extraordinary General Meeting planned for autumn[Stockholm, 15 May 2020] – Compared to the full year run-rate of 3.3 million Engine Equivalents in 2019, annualised series production decreased to 2.4 million Engine Equivalents in March and further to 1.0 million Engine Equivalents in April. Annualised series production for the first four months of the year is down 25%, from 3.2 million Engine Equivalents in 2019 to 2.4 million Engine Equivalents in 2020. Although the production has started to show signs of recovery in May, the Board of Directors judges that it is still too early to quantify

Changes in HiQ's organisation in Skåne

Anna Kleine, Managing Director of HiQ's subsidiary in Skåne, has chosen to move on for a new job as CEO of a non-competing company in the IT industry. Anna will continue to lead the operations in Skåne during her period of notice until she leaves HiQ towards the end of Q3.“Anna has since the beginning been involved in building a strong and successful business in Skåne. I would like to send a big thanks to Anna for all the commitment she has given to HiQ and wish her luck when she leaves us this fall. And look forward to working together as a client or partner", says Lars Stugemo, President

Kamux Corporation’s Interim Report for January 1 - March 31, 2020

Kamux Corporation                Interim Report                      May 15, 2020 at 09:00 Kamux Corporation’s Interim Report for January 1 - March 31, 2020 Kamux’s revenue grew strongly by 17.0% and its financial position strengthened The figures in parentheses refer to the comparison period, i.e. the same period in the previous year, unless stated otherwise. January-March in brief - Revenue increased by 17.0%, totaling EUR 167.4 million (143.0) - Gross profit increased by 10.0% to EUR 18.3 million (16.6), or 10.9% (11.6) of revenue - Adjusted operating profit (EBIT)

There are no items matching the current filter
There are no more items matching the current filter
Back to top